✦ LIBER ✦

Perusing the ASCO abstracts with a focus on interferons in malignant melanoma and renal cell carcinoma

✍ Scribed by Stephen K. Carter

Book ID: 104693933
Publisher: Springer
Year: 1984
Tongue: English
Weight: 259 KB
Volume: 13
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00269020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A feasibility study of roquinimex (Linom

A feasibility study of roquinimex (Linomide) and alpha interferon in patients with advanced malignant melanoma or renal carcinoma

✍ Mackean, MJ; Kerr, D; Lesko, M; Svedberg, A; Hansson, F; Jodrell, D; Cassidy, J 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 666 KB

883 POSTER Phase I trial of sorafenib (B

883 POSTER Phase I trial of sorafenib (BAY 43–9006) in combination with interferon alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma and malignant melanoma

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB

A phase I study of recombinant human int

A phase I study of recombinant human interleukin-2 and alpha-interferon-2a in patients with renal cell cancer, colorectal cancer, and malignant melanoma

✍ A. Mittelman; M. Huberman; C. Puccio; B. Fallon; J. Tessitore; S. Savona; R. Eyr 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 662 KB

Preclinical data suggest synergy of interleukin-2 (IL-2) combined with alphainterferon (IFN). In addition, toxicities of IL-2 may be decreased by intermittent continuous infusion. The purpose of this trial was to determine the maximum tolerated dose (MTD) of recombinant IL-2 combined with alpha-IFN

A combination of subcutaneous recombinan

A combination of subcutaneous recombinant interleukin-2 and recombinant interferon-α in the treatment of advanced renal cell carcinoma or melanoma

✍ Vuoristo, Merisisko; Jantunen, Ismo; Pyrhönen, Seppo; Muhonen, Timo; Kellokumpu- 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 410 KB

The hematologic toxicity of interleukin-

The hematologic toxicity of interleukin-2 in patients with metastatic melanoma and renal cell carcinoma

✍ Mark P. Macfarlane; James C. Yang; Anshu S. Guleria; Richard L White Jr.; Claudi 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 744 KB

Treatment of malignant melanoma and rena

Treatment of malignant melanoma and renal cell carcinoma with recombinant human interleukin-2: analysis of cytokine levels in sera and culture supernatants

✍ McIntyre, Catherine A.; Chapman, Karen; Reeder, Steve; Dorreen, Mark S.; Bruce, 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 804 KB